Salvage Therapy Including Foscarnet and Ibalizumab for Multidrug-Resistant Human Immunodeficiency Virus Type 2 InfectionAntoine Bachelard, Minh Lê, Gilles Peytavin et al.|Clinical Infectious Diseases|2023Cited by 4
Increased risk of severe COVID-19 in hospitalized patients with SARS-CoV-2 Alpha variant infection: a multicentre matched cohort studyGuillaume Martin‐Blondel, Paul Chabert, François‐Xavier Lescure et al.|BMC Infectious Diseases|2022Cited by 2